T. Rowe Price Associates
GRDN

T. Rowe Price Associates’s Guardian Pharmacy Services GRDN Stock Holding History

T. Rowe Price Associates’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$609K Buy
16,164
+4,279
+36% +$140K ﹤0.01% 2364
2025
Q4 		$358K Buy
11,885
+1,409
+13% +$39.9K ﹤0.01% 2555
2025
Q3 		$275K Buy
+10,476
New +$250K ﹤0.01% 2641

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

T. Rowe Price Associates's GRDN Position: Q1 2026 in Review

T. Rowe Price Associates increased its Guardian Pharmacy Services (GRDN) stake by 36% in Q1 2026, buying an estimated $140K and bringing the position to 16,164 shares worth $609K. The position accounts for ﹤0.01% of the portfolio, ranked #2364.

T. Rowe Price Associates first reported a position in GRDN in Q3 2025 and has held it in 3 quarters since. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • T. Rowe Price Associates held 16,164 shares of Guardian Pharmacy Services worth $609K as of Q1 2026.
  • T. Rowe Price Associates bought 4,279 Guardian Pharmacy Services shares in Q1 2026, an estimated $140K.
  • Guardian Pharmacy Services made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2364 holding.
  • T. Rowe Price Associates first reported a position in Guardian Pharmacy Services in Q3 2025 and has held it in 3 quarters since.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.